Simon Andrea Koblar

Simon Andrea Koblar

Auto-generated profile, based on publicly available information

Simon Andrea Koblar

School of Medicine, The University of Adelaide, Adelaide, SA, Australia

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2008 in Stem Cells
Verified
Journal Article
Open access
PDF file
AAAgnes Arthur
Agnes Arthur
GRGrigori Rychkov
Grigori Rychkov
SSSongtao Shi
Songtao Shi
SKSimon Andrea Koblar
Simon Andrea Koblar
SGStan Gronthos
Stan Gronthos
Human adult dental pulp stem cells (DPSCs) reside within the perivascular niche of dental pulp and are thought to originate from migrating cranial neural crest (CNC) cells. During embryonic development, CNC cells differentiate into a wide variety of cell types, including neurons of the peripheral nervous system. Previously, we have demonstrated that DPSCs derived from adult human third molar teeth differentiate into cell types reminiscent of CNC embryonic ontology. We hypothesized that DPSCs exposed to the appropriate environmental cues would differentiate into functionally active neurons. The data demonstrated that ex vivo-expanded human adult DPSCs responded to neuronal inductive conditions both in vitro and in vivo. Human adult DPSCs, but not human foreskin fibroblasts (HFFs), acquired a neuronal morphology, and expressed neuronal-specific markers at both the gene and protein levels. Culture-expanded DPSCs also exhibited the capacity to produce a sodium current consistent with functional neuronal cells when exposed to neuronal inductive media. Furthermore, the response of human DPSCs and HFFs to endogenous neuronal environmental cues was determined in vivo using an avian xenotransplantation assay. DPSCs expressed neuronal markers and acquired a neuronal morphology following transplantation into the mesencephalon of embryonic day-2 chicken embryo, whereas HFFs maintained a thin spindle fibroblastic morphology. We propose that adult human DPSCs provide a readily accessible source of exogenous stem/precursor cells that have the potential for use in cell-therapeutic paradigms to treat neurological disease. Disclosure of potential conflicts of interest is found at the end of this article.

5 January 2018 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
AGAnupam Datta Gupta
Anupam Datta Gupta
WCWing Hong Chu
Wing Hong Chu
SHStuart Howell
Stuart Howell
SCSubhojit Chakraborty
Subhojit Chakraborty
SKSimon Koblar
Simon Koblar
DWDavid Wilson
David Wilson
Improved walking is one of the highest priorities in people living with stroke. Post-stroke lower limb spasticity (PSLLS) impedes walking and quality of life (QOL). The understanding of the evidence of improved walking and QOL following botulinum toxin (BoNTA) injection is not clear. We performed a systematic review of the randomized control trials (RCT) to evaluate the effectiveness of BoNTA injection on walking and QOL in PSLLS. We searched PubMed, Web of Science, Embase, CINAHL, ProQuest Thesis and Dissertation checks, Google Scholar, WHO International Clinical Trial Registry Platform, ClinicalTrials.gov , Cochrane, and ANZ and EU Clinical Trials Register for RCTs looking at improvement in walking and QOL following injection of BoNTA in PSLLS. The original search was carried out prior to 16 September 2015. We conducted an additional verifying search on CINHAL, EMBASE, and MEDLINE (via PubMed) from 16 September 2015 to 6 June 2017 using the same clauses as the previous search. Methodological quality of the individual studies was critically appraised using Joanna Briggs Institute’s instrument. Only placebo-controlled RCTs looking at improvement in walking and QOL were included in the review. Of 2026 records, we found 107 full-text records. Amongst them, we found five RCTs qualifying our criteria. No new trials were found from the verifying search. Two independent reviewers assessed methodological validity prior to inclusion in the review using Joanna Briggs Institute’s appraisal instrument. Two studies reported significant improvement in gait velocity (p = 0.020) and < 0.05, respectively. One study showed significant improvement in 2-min-walking distance (p < 0.05). QOL was recorded in one study without any significant improvement. Meta-analysis of reviewed studies could not be performed because of different methods of assessing walking ability, small sample size with large confidence interval and issues such as lack of power calculations in some studies. Findings from our systematic and detailed study identify the need for a well-designed RCT to adequately investigate the issues highlighted. This review could not conclude there was sufficient evidence to support or refute improvement on walking or QOL following BoNTA injection. Reasons for this are discussed, and methods for future RCTs are developed.

17 March 1998 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SKS. A. Koblar
S. A. Koblar
ATA. M. Turnley
A. M. Turnley
BCB. J. Classon
B. J. Classon
KRK. L. Reid
K. L. Reid
CWC. B. Ware
C. B. Ware
PBP. F. Bartlett
P. F. Bartlett
The differentiation of precursor cells into neurons or astrocytes in the developing brain has been thought to be regulated in part by growth factors. We show here that neural precursors isolated from the developing forebrain of mice that are deficient in the gene for the low-affinity leukemia inhibitory factor receptor (LIFR −/− ) fail to generate astrocytes expressing glial fibrillary acidic protein (GFAP) when cultured in vitro . Precursors from mice heterozygous for the null allele show normal levels of GFAP expression. These findings support the in vivo findings that show extremely low levels of GFAP mRNA in brains of embryonic day 19 LIFR −/− mice. In addition, monolayers of neural cells from LIFR −/− mice are far less able to support the neuronal differentiation of normal neural precursors than are monolayers from heterozygous or wild-type animals, indicating that endogenous signaling through the LIFR is required for the expression of both functional and phenotypic markers of astrocyte differentiation. LIFR −/− precursors are not irreversibly blocked from differentiating into astrocytes: they express GFAP after long-term passaging or stimulation with bone morphogenetic protein-2. These findings strongly implicate the LIF family of cytokines in the regulation of astrocyte differentiation and indeed the LIF-deficient animals show a significant reduction in the number of GFAP cells in the hippocampus. However, because this reduction is only partial it suggests that LIF may not be the predominant endogenous ligand signaling through the LIFR.

2 September 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EHElizabeth Holliday
Elizabeth Holliday
JMJane Maguire
Jane Maguire
TETiffany-Jane Evans
Tiffany-Jane Evans
SKSimon A Koblar
Simon A Koblar
JJJim Jannes
Jim Jannes
JAJohn Attia
John Attia

22 February 2012 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
WLWai Khay Leong
Wai Khay Leong
THTanya L. Henshall
Tanya L. Henshall
AAAgnes Arthur
Agnes Arthur
KKKarlea L. Kremer
Karlea L. Kremer
MLMartin D. Lewis
Martin D. Lewis
SKSimon A. Koblar
Simon A. Koblar
Human adult dental pulp stem cells (DPSCs), derived from third molar teeth, are multipotent and have the capacity to differentiate into neurons under inductive conditions both in vitro and following transplantation into the avian embryo. In this study, we demonstrate that the intracerebral transplantation of human DPSCs 24 hours following focal cerebral ischemia in a rodent model resulted in significant improvement in forelimb sensorimotor function at 4 weeks post-treatment. At this time, 2.3 ± 0.7% of engrafted cells had survived in the poststroke brain and demonstrated targeted migration toward the stroke lesion. In the peri-infarct striatum, transplanted DPSCs differentiated into astrocytes in preference to neurons. Our data suggest that the dominant mechanism of action underlying DPSC treatment that resulted in enhanced functional recovery is unlikely to be due to neural replacement. Functional improvement is more likely to be mediated through DPSC-dependent paracrine effects. This study provides preclinical evidence for the future use of human DPSCs in cell therapy to improve outcome in stroke patients.

4 June 2009 in Stem Cells
Verified
Journal Article
Closed access
PDF file
AAAgnieszka Arthur
Agnieszka Arthur
SSSongtao Shi
Songtao Shi
AZAndrew Zannettino
Andrew Zannettino
NFNobutaka Fujii
Nobutaka Fujii
SGStan Gronthos
Stan Gronthos
SKSimon A. Koblar
Simon A. Koblar